loader2
Login Open ICICI 3-in-1 Account

Entry Price

475.00

Target

555.00

Recommend Date

06-02-2021

Return

16.84 %
BUY

Date : 06-02-2021

Q3FY21 revenues grew 4.3% YoY to | 3796 crore (I-direct estimate: | 3906 crore). Domestic formulations posted strong growth of 21.2% YoY to | 1104 crore. However, US sales declined 4.3% YoY to | 1603 crore. Wellness segment also grew a robust 15.8% YoY to | 376 crore. Emerging markets grew 10.9% YoY to | 293 crore. API segment de-grew 18.8% YoY to | 132 crore. Animal health segment grew 17.0% YoY to | 163 crore. EBITDA margins expanded 220 bps YoY to 21.3% (I-direct estimate: 21.2%) due to a better overall operational performance. Subsequently, EBITDA grew 16.4% YoY to | 807 crore (I-direct estimate: | 828 crore). Adjusted PAT grew 40.5% YoY to | 527 crore (I-direct estimates: | 495 crore).